Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
ERNA holding history
Ernexa Therapeutics Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ERNA overviewAll 13F holders of ERNAFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −30−100.0% | Sold out | Holders |
| Q4 2025 | 30 | $36 | <0.1% | −47−61.0% | Reduced | Holders |
| Q3 2025 | 77 | $84 | <0.1% | −477−86.1% | Reduced | Holders |
| Q2 2025 | 554 | $1.02K | <0.1% | +554 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −50−100.0% | Sold out | Holders |
| Q3 2024 | 50 | $53 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 50 | $92 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 50 | $120 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 50 | $90 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 50 | $109 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 50 | $113 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 50 | $170 | <0.1% | −1,313−96.3% | Reduced | Holders |
| Q4 2022 | 1,363 | $4.39K | <0.1% | +1,363 | New | Holders |